| Application no. and date | 19711866.4 (espacenet) (Federated) (European Patent Register), 20190313 | | Patent/reg. no. and date | DK/EP 3765024, 20231122 | | Publication date | 20210120 | | Priority no. and date | US 201862642622 P, 20180314 | | EP pub. no. and date |
EP 3765024 20210120 | | Effective date | | | Applicant/owner | KaNDy Therapeutics Limited, 400 South Oak Way
Reading, Berkshire RG2 6AD, GB | | Applicant ref. no. | 1679548 | | Inventor | TROWER, Mike, C/O NeRRe Therapeutics Limited
Stevenage Bioscience Catalyst
Incubator Building
Gunnels Wood Road
Stevenage
Hertfordshire SG1 2FX, GB,
KERR, Mary, C/O NeRRe Therapeutics Limited Stevenage
Bioscience Catalyst Incubator Building Gunnels
Wood Road
Stevenage Hertfordshire SG1 2FX, GB,
ELDER, David, 110 Fordwich Rise
Hertford, Hertfordshire SG14 2DE, GB,
LAZARO, Monica, C/O Catalent Pharma Solutions 2725 Scherer Drive
St. Petersburg, Florida 33716, US,
BUSH, Derek, C/O Catalent Pharma Solutions 2725 Scherer Drive
St. Petersburg, Florida 33716, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/5383 (2006.01) , A61K 47/14 (2017.01) , A61K 9/08 (2006.01) , A61K 9/48 (2006.01) , A61P 25/00 (2006.01) , A61P 5/24 (2006.01) , C07D 498/04 (2006.01) | | Title | HIDTIL UKENDT FARMACEUTISK FORMULERING, SOM OMFATTER DOBBELTE NK-1/NK-3-RECEPTOR-ANTAGONISTER | | Int. application no. | EP2019056303 | | Int. publication no. | WO2019175253 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
